These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. An uncommon presentation of a common disease: the hypertension of Cushing's syndrome. Ellsbury KE J Fam Pract; 1987 Sep; 25(3):289-90, 292. PubMed ID: 3625145 [No Abstract] [Full Text] [Related]
26. [Use of aminoglutethimide in the treatment of Cushing's syndrome]. Jacobelli A; Borgia MC; Borgia C; Sellini M Minerva Med; 1974 Jan; 65(3):156-62. PubMed ID: 4370585 [No Abstract] [Full Text] [Related]
28. [A rare case of Itsenko-Cushing disease accompanied by gangrene of the fingers and cryoglobulinemia]. Petkova M; Manov A; Baleva M; Tsanev A Vutr Boles; 1990; 29(6):91-4. PubMed ID: 2091393 [TBL] [Abstract][Full Text] [Related]
29. [Arterial hypertension in Cushing's disease]. Zbranca E; Abu Mizar S; Moscovici R Rev Med Chir Soc Med Nat Iasi; 1984; 88(2):273-8. PubMed ID: 6545002 [No Abstract] [Full Text] [Related]
30. [Benign intracranial hypertension following the suspension of corticotherapy in a female patient previously operated on for Cushing's disease]. Lucas A; Coll J; Salinas I; SanmartĂ A Med Clin (Barc); 1991 Oct; 97(12):473. PubMed ID: 1753818 [No Abstract] [Full Text] [Related]
31. The hypertension of Cushing's syndrome. Hollifield JW J Tenn Med Assoc; 1976 Mar; 69(3):199-200. PubMed ID: 1256052 [No Abstract] [Full Text] [Related]
33. [Gynecomastia during long term treatment of Cushing's disease with OP'DDD]. Luton JP; Valcke JC; Remy JM; Mathieu de Fossey B; Bricaire H Ann Endocrinol (Paris); 1972; 33(3):290-3. PubMed ID: 4650589 [No Abstract] [Full Text] [Related]
34. Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome. Kristo C; Ueland T; Godang K; Aukrust P; Bollerslev J J Endocrinol Invest; 2008 May; 31(5):400-5. PubMed ID: 18560257 [TBL] [Abstract][Full Text] [Related]
35. The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications. Isidori AM; Graziadio C; Paragliola RM; Cozzolino A; Ambrogio AG; Colao A; Corsello SM; Pivonello R; J Hypertens; 2015 Jan; 33(1):44-60. PubMed ID: 25415766 [TBL] [Abstract][Full Text] [Related]
36. Cardiovascular and renal complications of Cushing's syndrome. SCHOLZ DA; SPRAGUE RG; KERNOHAN JW N Engl J Med; 1957 May; 256(18):833-7. PubMed ID: 13451949 [No Abstract] [Full Text] [Related]
37. [Osteoporosis with Cushing's syndrome. On the problem of its control by surgical treatment]. Maurer HJ; Bayer JM Verh Dtsch Ges Inn Med; 1965; 71():877-80. PubMed ID: 5877712 [No Abstract] [Full Text] [Related]
39. Cushing's syndrome--a reversible cause of malignant hypertension. Soule SG; Rajpaul S; Levitt NS; Bryer A; Abrahamson MJ S Afr Med J; 1993 Oct; 83(10):800. PubMed ID: 8191340 [No Abstract] [Full Text] [Related]
40. [Cushing's syndrome and hypertension, with special reference to 38 cases seen at our clinic]. Miura K Horumon To Rinsho; 1971 Jun; 19(6):457-61. PubMed ID: 5165114 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]